Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture

Authors

James A. Simon, George Washington UniversityFollow
Christopher Recknor, United Osteoporosis Centers, Gainesville, GA
Alfred H. Moffett Jr., OB-GYN Associates of Mid Florida, Leesburg, FL
Jonathan D. Adachi, McMaster University, Hamilton, Canada
Edward Franek, Polish Academy of Sciences, Warsaw, Poland
E. Michael Lewiecki, University of New Mexico
Michael R. McClung, Oregon Osteoporosis Center, Portland, OR
Carlos A. Mautalen, Centro de Osteopatias Medicas, Buenos Aires, Argentina
Sergio Ragi-Eis, Centro de Diagnostico e Pesquisa, Vitória, Brazil
Geoffrey C. Nicholson, University of Queensland, Toowoomba, Australia
Christian Muschitz, St Vincent Hospital, Vienna, Austria
Ranuccio Nuti, University of Siena, Siena, Italy
Ove Torring, Karolinska Institutet Södersjukhuset, Stockholm, Sweden
Andrea Wang, Amgen Inc., Thousand Oaks, CA
Cesar Libanati, Amgen Inc., Thousand Oaks, CA

Document Type

Journal Article

Publication Date

2-2013

Journal

Menopause

Volume

Volume 20, Issue 2

Inclusive Pages

130-137

Keywords

Antibodies; Monoclonal; Humanized--therapeutic use; Bone Density--drug effects; Bone Density Conservation Agents--therapeutic use; Bone and Bones--physiopathology; Osteoporosis; Postmenopausal--drug therapy; RANK Ligand--antagonists & inhibitors; Radius--physiopathology

APA Citation

Simon, J. A., Recknor, C., Moffett, A. H., Adachi, J. D., Franek, E., Lewiecki, E. M., McClung, M.R., Mautalen, C.A., Ragi-Eis, S., Nicholson, G.C., Muschitz, C., Nuti, R.l, Törring, O., Wang, A., Libanati, C. (2013). Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: Bone density, mass, and strength of the radius, and wrist fracture. Menopause, 20(2), 130-137.

Peer Reviewed

1